NF1 and fragile X syndrome: This confirms previous genetic studies suggesting that defects in the PI3K/mTOR pathway may be a shared pathomechanism in a sub-cohort of individuals with autism [20], in addition to the known syndromic cases associated with altered PI3K/mTOR signaling (such as FXS, TS, and NF-1).